Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michael L. Bowe"'
Autor:
Cicely L. Schramm, Michael L. Bowe, Laura A. Skerlos, Grigory S. Filonov, Yong X. Chen, Daniel M. Appledorn
Publikováno v:
Cancer Research. 79:5266-5266
Differential metabolic requirements of tumor cells have gained recognition as attractive therapeutic targets. For example, clinical trials are currently underway to test the efficacy of the glutaminase-1 (GLS1) inhibitor CB-839 in a variety of indica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03bcf45f63e94c17a5a43261692bac02
https://doi.org/10.1158/1538-7445.am2019-5266
https://doi.org/10.1158/1538-7445.am2019-5266
Autor:
Dyke P. McEwen, Cicely L. Schramm, Michael L. Bowe, Daniel M. Appledorn, Yong X. Chen, Grigory S. Filonov, Laura A. Skerlos
Publikováno v:
Cancer Research. 78:374-374
Metabolic reprogramming is a hallmark of tumor cells, owing to the increased energetic and biosynthetic demands associated with maintaining high rates of proliferation. Therapeutic strategies targeting unique, critical metabolic pathways of tumor cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2453888f07eedeceeb9f6eae14c4a36d
https://doi.org/10.1158/1538-7445.am2018-374
https://doi.org/10.1158/1538-7445.am2018-374